Clinical Neuromuscular Pathology Certification Examination Committee Contributors
Mazen Mohammad Dimachkie, MD, Chair, University of Kansas Medical Center
Disclosures: Serves or recently served as a consultant for Amazentis, ArgenX, Catalyst, Cello, Covance/Labcorp, CSL-Behring, EcoR1, Janssen, Kezar, Medlink, Momenta, NuFactor, Octapharma, RaPharma/UCB, Roivant Sciences Inc, Sanofi Genzyme, Shire Takeda, Scholar Rock, Spark Therapeutics, Abata/Third Rock, UCB Biopharma and UpToDate; DMC for Covance/LabCorp; received research grants or contracts or educational grants from Alexion, Alnylam Pharmaceuticals, Amicus, Biomarin, Bristol-Myers Squibb, Catalyst, Corbus, CSL-Behring, FDA/OOPD, GlaxoSmithKline, Genentech, Grifols, Kezar, Mitsubishi Tanabe Pharma, MDA, NIH, Novartis, Octapharma, Orphazyme, Ra Pharma/UCB, Sanofi Genzyme, Sarepta Therapeutics, Shire Takeda, Spark Therapeutics, The Myositis Association, UCB Biopharma / RaPharma, Viromed/Healixmith & TMA; received other compensation from Medlink and UpToDate.
Michelle Lynn Mauermann, MD, Vice Chair, Mayo Clinic – Rochester
Disclosures: Receives research support from Alnylam, IONIS, and EIDOS for amyloid clinical trials.
Rocio Carolina Garcia Santibanez, MD, Emory Brain Health Center
Disclosures: Nothing to disclose.
Ahmed Mohamed Attia El-Dokla, MD, Neuromuscular Clinic at Upstate Bone & Joint
Disclosures: Nothing to disclose.
Shalini Mahajan, MD, Cedars-Sinai Medical Center
Disclosures: Nothing to disclose.
Raghav Govindarajan, MD, St. Elizabeth Medical Group, Illinois
Disclosures: Received compensation from Appellis pharma, DSMB chair; speakers bureau fees from Alexion Argenx; research support from MDA, ALSA, Alexion; royalties from Springer Cambridge.
Margherita Milone, MD, PhD, Mayo Clinic – Rochester
Disclosures: Received compensation from AAN to serve as associate editor of Neurology Genetics; research support from Mayo Clinic.
Aziz Shaibani, MD, Nerve and Muscle Center of Texas
Disclosures: Nothing to disclose.
Anthony A. Amato, MD, Brigham and Women's Hospital
Disclosures: Received compensation from Teledoc/Best Doctors: provide second opinion on challenging cases; MAB/consultant for Ra Pharma, Horizon Pharmaceuticals, Abcuro, Argenx, EMD Serano, Orphazyme, Ono Pharma to discuss possible treatments for various neuromuscular disease and design of trials; Associate Editor of Neurology; reviewed medical records and provided deposition testimony on medical malpractice cases.
Mohamed Kazamel, MD, University of Alabama at Birmingham
Disclosures: Received compensation from Alnylam Pharmaceuticals for consulting service.